Clinical Trials Logo

Clinical Trial Summary

This FDA-approved (IND# 120700) study will evaluate efficacy of intranasal insulin in reducing snack intake and reducing postprandial free fatty acid levels in abstinent smokers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02028871
Study type Interventional
Source University of New Mexico
Contact
Status Completed
Phase Phase 2
Start date July 2014
Completion date May 2016

See also
  Status Clinical Trial Phase
Completed NCT01781234 - Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome Phase 2